EncuraGen, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (PEG)-BHD1028 (NCT06563115) | EncuraGen, Inc | 2022-04-18 |
Track EncuraGen, Inc automatically
Every clearance here is in the API, with alerts when new ones post.